Literature DB >> 27586162

Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.

I Matak1, Z Lacković2, M Relja3.   

Abstract

In the motor system, botulinum toxin type A (BoNT/A) actions were classically attributed to its well-known peripheral anticholinergic actions in neuromuscular junctions. However, the enzymatic activity of BoNT/A, assessed by the detection of cleaved synaptosomal-associated protein 25 (SNAP-25), was recently detected in motor and sensory regions of the brainstem and spinal cord after toxin peripheral injection in rodents. In sensory regions, the function of BoNT/A activity is associated with its antinociceptive effects, while in motor regions we only know that BoNT/A activity is present. Is it possible that BoNT/A presence in central motor nuclei is without any function? In this brief review, we analyze this question. Limited data available in the literature warrant further investigations of BoNT/A actions in motor nervous system.

Entities:  

Keywords:  Botulinum toxin type A; Central effect; Motor regions; Synaptosomal-associated protein 25

Mesh:

Substances:

Year:  2016        PMID: 27586162     DOI: 10.1007/s00702-016-1611-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  53 in total

1.  Remote F-wave changes after local botulinum toxin application.

Authors:  K Wohlfarth; M Schubert; B Rothe; J Elek; R Dengler
Journal:  Clin Neurophysiol       Date:  2001-04       Impact factor: 3.708

Review 2.  On muscle spindles, dystonia and botulinum toxin.

Authors:  R L Rosales; D Dressler
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

Review 3.  More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.

Authors:  Riccardo Mazzocchio; Matteo Caleo
Journal:  Neuroscientist       Date:  2014-02-26       Impact factor: 7.519

4.  The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord.

Authors:  J Mika; E Rojewska; W Makuch; M Korostynski; S Luvisetto; S Marinelli; F Pavone; B Przewlocka
Journal:  Neuroscience       Date:  2010-11-25       Impact factor: 3.590

5.  Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.

Authors:  Laura Restani; Elena Novelli; David Bottari; Paola Leone; Ilaria Barone; Lucia Galli-Resta; Enrica Strettoi; Matteo Caleo
Journal:  Traffic       Date:  2012-05-09       Impact factor: 6.215

6.  Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.

Authors:  Christine Favre-Guilmard; Michel Auguet; Pierre-Etienne Chabrier
Journal:  Eur J Pharmacol       Date:  2009-07-01       Impact factor: 4.432

7.  Lack of anti-inflammatory effect of botulinum toxin type A in experimental models of inflammation.

Authors:  Lidija Bach-Rojecky; Mara Dominis; Zdravko Lacković
Journal:  Fundam Clin Pharmacol       Date:  2008-08-20       Impact factor: 2.748

Review 8.  Physiological effects of botulinum toxin in spasticity.

Authors:  Jean-Michel Gracies
Journal:  Mov Disord       Date:  2004-03       Impact factor: 10.338

9.  Functional evaluation of biological neurotoxins in networked cultures of stem cell-derived central nervous system neurons.

Authors:  Kyle Hubbard; Phillip Beske; Megan Lyman; Patrick McNutt
Journal:  J Vis Exp       Date:  2015-02-05       Impact factor: 1.355

10.  Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative.

Authors:  Jacob M Scherf; Xiaoyang Serene Hu; William H Tepp; Konstantin Ichtchenko; Eric A Johnson; Sabine Pellett
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

View more
  3 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

2.  Evidence for central antispastic effect of botulinum toxin type A.

Authors:  Ivica Matak
Journal:  Br J Pharmacol       Date:  2019-11-06       Impact factor: 8.739

Review 3.  The Expanding Therapeutic Utility of Botulinum Neurotoxins.

Authors:  Elena Fonfria; Jacquie Maignel; Stephane Lezmi; Vincent Martin; Andrew Splevins; Saif Shubber; Mikhail Kalinichev; Keith Foster; Philippe Picaut; Johannes Krupp
Journal:  Toxins (Basel)       Date:  2018-05-18       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.